Evid Invest
Who owns OVIDWhat OVID owns — n/a

Who owns Ovid Therapeutics Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of OVID from SEC Form 13F filings across 129 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 129 institutions disclosed 148.4M shares of Ovid Therapeutics Inc. worth $369.4M — about 201.3% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.

129

13F holders

$369.4M

value, 2026 filers

201.3%

of shares outstanding (148.4M sh)

15

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of OVID's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Janus Henderson Group Ltd.NEW20.7M$51.5M0.0%28.1%new
2BlackRock, Inc.12.1M$30.0M0.0%16.3%+11.3%
3EVENTIDE ASSET MANAGEMENT, LLC11.8M$29.4M0.4%16%0.0%
4Affinity Asset Advisors, LLC10.1M$25.3M1.0%13.8%0.0%
5VANGUARD CAPITAL MANAGEMENT LLC7.8M$19.5M0.0%10.6%+0.9%
6Balyasny Asset Management L.P.7.1M$17.7M0.0%9.7%+5.9%
7BRAIDWELL LP6.6M$16.4M0.7%8.9%+11.2%
8STATE STREET CORP6.2M$15.4M0.0%8.4%-21.5%
9ADAGE CAPITAL PARTNERS GP, L.L.C.6.2M$15.3M0.0%8.4%0.0%
10FEDERATED HERMES, INC.6.0M$14.8M0.0%8.1%0.0%
11SILVERARC CAPITAL MANAGEMENT, LLC6.0M$14.8M1.7%8.1%+91.9%
12RA CAPITAL MANAGEMENT, L.P.5.6M$13.9M0.1%7.6%-46.7%
13ADAR1 Capital Management, LLC4.6M$11.4M0.5%6.2%-38.5%
14GEODE CAPITAL MANAGEMENT, LLC4.3M$10.7M0.0%5.8%+5.6%
15Integral Health Asset Management, LLCNEW3.5M$8.7M0.5%4.7%new
16Point72 Asset Management, L.P.2.5M$6.3M0.0%3.5%+31.0%
17Ikarian Capital, LLC2.1M$5.3M0.5%2.9%-6.6%
18VANGUARD PORTFOLIO MANAGEMENT LLC1.7M$4.2M0.0%2.3%+61.7%
19SPHERA FUNDS MANAGEMENT LTD.1.6M$4.0M0.6%2.2%+18.3%
20NORTHERN TRUST CORP1.3M$3.2M0.0%1.8%+4.6%
21STEMPOINT CAPITAL LP1.3M$3.2M0.6%1.7%-46.7%
22VANGUARD FIDUCIARY TRUST CO1.2M$3.0M0.0%1.6%+4.8%
23Rosalind Advisors, Inc.1.1M$2.8M0.9%1.5%0.0%
24Propel Bio Management, LLC1.0M$2.5M1.3%1.4%-8.7%
25Atom Investors LP1.0M$2.5M0.1%1.4%+303.8%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.